Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
Status:
Recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
12-week, randomized, double-blind, placebo-controlled, parallel-group study of carbetocin
nasal spray for the treatment of hyperphagia in Prader-Willi syndrome (PWS)